Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
SIF vs KOPN: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
SIF Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 8–2 Matrix Metrics)
SIF Overall Winner
6-Pillar Tally: SIF 4 – 2 KOPN
Matrix Metrics: SIF 8 – 2 KOPN
As of Nov 20, 2026, SIFCO Industries, Inc. (SIF) is the stronger overall head-to-head candidate over Kopin Corp (KOPN) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). SIF carries a Unified Composite Score of 51.4/100 (HOLD) at $14.02 (11.2x Forward P/E, 5.1% operating margin), whereas KOPN carries 50.7/100 (HOLD) at $2.58 (N/M Forward P/E, -30.5% operating margin).
- Growth vs. Quality Trade-Off: SIF earns the overall head-to-head edge with a stronger Unified Composite Score (51.4/100 HOLD vs. KOPN 50.7/100 HOLD) and 1.94β · 67% Vol risk profile, whereas KOPN leads top-line expansion (+52.1% YoY revenue growth, 17.03x PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates.
- Technical & Structure Timing Caution: SIF is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 26.6); meanwhile KOPN is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Executive Snapshot Side-by-Side Composite Ratings & Technical Regime
Ask Alpha AI About SIF vs KOPN
SIF
Head-to-Head Winner
SIFCO Industries, Inc.
$14.02
-4.82% 1D
Market Cap
$89.7M
TTM Revenue
$99M
Forward P/E
11.2x
Beta / 30D Vol
1.94β · 67% Vol
Unified Composite Score
51.4
HOLD
Tech 50.0
Fund 57.0
Flow 50.0
Mom 59.0
Weinstein Technical Phase
Markdown · Sell / avoid
KOPN
Kopin Corp
$2.58
-9.33% 1D
Market Cap
$528.3M
TTM Revenue
$200M
Forward P/E
N/M
Beta / 30D Vol
4.57β · 123% Vol
Unified Composite Score
50.7
HOLD
Tech 33.0
Fund 62.0
Flow 58.0
Mom 64.0
Weinstein Technical Phase
Markdown · Sell / avoid
6-Pillar Scorecard Institutional Category Breakdown (SIF 4 – 2 KOPN)
1. Valuation Multiples
SIF
Forward P/E
11.2x
N/M
Trailing P/E
23.4x
N/M
PEG Ratio
1.64x
17.03x
EV / Revenue
1.0x
2.1x
2. Growth & Scale
KOPN
Revenue Growth (YoY)
+18.3%
+52.1%
Earnings Growth (YoY)
N/A
+0.0%
TTM Revenue (USD)
$99M
$200M
Market Cap
$89.7M
$528.3M
3. Profitability & Quality
SIF
Gross Margin
16.6%
28.8%
Operating Margin
5.1%
-30.5%
Net Profit Margin
4.0%
0.9%
Return on Equity (ROE)
10.1%
1.1%
4. Balance Sheet & Cash Flow
SIF
Cash Generation (TTM)
$3.0M
-$69M
Cash Flow Margin
3.0%
-34.4%
Net Cash / Leverage
$9.1M Net Debt (0.43x D/E)
$99M Net Cash
Dividend Yield
None (0.00%)
None (0.00%)
5. Options & Positioning
SIF
Options Structure Phase
UNCLASSIFIED
BREAKDOWN
Current IV / %ile
N/A (N/A)
93.3% (14th %ile)
Put/Call OI Skew
N/A
0.45x (Call-Skewed)
OBV Trend / Tech Phase
NEUTRAL · Markdown
DISTRIBUTION · Markdown
6. R&D & Supply-Chain Moat
KOPN
OpEx & R&D Intensity
11.5% of Rev ($11M)
59.3% of Rev ($119M)
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Cyclical / Execution-Driven Positioning
Cyclical / Execution-Driven Positioning
Supply-Chain Role
Aerospace & Defense Operator
Aerospace & Defense Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: SIF (8) vs KOPN (2)| Institutional Metric | SIF | KOPN | Criterion | Row Edge |
|---|---|---|---|---|
| Market Capitalization | $89.7M | $528.3M | KOPN | |
| Trailing P/E Ratio | 23.4x | N/M | SIF | |
| Forward P/E Ratio | 11.2x | N/M | SIF | |
| Revenue Growth (YoY) | +18.3% | +52.1% | KOPN | |
| Operating Margin (TTM) | 5.1% | -30.5% | SIF | |
| Net Profit Margin | 4.0% | 0.9% | SIF | |
| Return on Equity (ROE) | 10.1% | 1.1% | SIF | |
| 52-Week Range Position | 38% ($5–$29) | 16% ($2–$7) | SIF | |
| Beta / 30D Volatility | 1.94β · 67% Vol | 4.57β · 123% Vol | SIF | |
| Unified Institutional Score | 51.4 / 100 (HOLD) | 50.7 / 100 (HOLD) | SIF | |
| Trailing 12M Revenue (USD) | $99M | $200M | Scale | |
| Gross Profit Margin (TTM) | 16.6% | 28.8% | Quality | |
| PEG Ratio & EV / Revenue | 1.64x PEG · 1.0x EV/Rev | 17.03x PEG · 2.1x EV/Rev | Valuation | |
| Cash Flow & Balance Sheet | $3.0M ($9.1M Net Debt (0.43x D/E)) | -$69M ($99M Net Cash) | Solvency |
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M Horizon
KOPN +7.36 pp
3M Horizon
SIF +11.87 pp
6M Horizon
SIF +20.89 pp
1Y Horizon
SIF +108.75 pp
Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | SIF Revenue | KOPN Revenue | SIF Op. Margin | KOPN Op. Margin | Margin Leader |
|---|---|---|---|---|---|
| FY2018 | $110M | $20M | -5.3% | -163.4% | SIF |
| FY2019 | $110M | $30M | -6.3% | -89.4% | SIF |
| FY2020 | $110M | $40M | 8.9% | -11.9% | SIF |
| FY2021 | $100M | $50M | -1.1% | -30.2% | SIF |
| FY2022 | $80M | $50M | -16.8% | -46.0% | SIF |
| FY2023 | $70M | $40M | -13.6% | -42.5% | SIF |
| FY2024 | $80M | $50M | -6.5% | -85.6% | SIF |
| FY2025 | $80M | $40M | 0.2% | -25.1% | SIF |
Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor
Live Options Phase Tracker
SIF
UNCLASSIFIED
Current IV
N/A
IV Percentile
N/A
Put/Call OI Skew
N/A
IV Regime
Unclassified
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
NEUTRAL
OBV Flow
NEUTRAL
Exact SIF Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
KOPN
BREAKDOWN
Current IV
93.3%
IV Percentile
14th %ile
Put/Call OI Skew
0.45x (Call-Skewed)
IV Regime
Compressed (<25th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BULLISH
OBV Flow
DISTRIBUTION
Exact KOPN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity
Corporate R&D & Foundry Leaderboard
SIF Moat Profile
Cyclical / Execution-Driven Positioning
Aerospace & Defense Operator
OpEx & R&D Reinvestment
11.5% of Rev ($11M)
90D Engineering Disclosures
0 Published
KOPN Moat Profile
Cyclical / Execution-Driven Positioning
Aerospace & Defense Operator
OpEx & R&D Reinvestment
59.3% of Rev ($119M)
90D Engineering Disclosures
0 Published
Taiwan Semiconductor Manufacturing Company
GlobalFoundries
Corning
Universal Display Corporation
Investor FAQ SIF vs KOPN Key Questions & Quantitative Answers
As of Nov 20, 2026, SIFCO Industries, Inc. (SIF) is the stronger overall head-to-head candidate over Kopin Corp (KOPN) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). SIF carries a Unified Composite Score of 51.4/100 (HOLD) at $14.02 (11.2x Forward P/E, 5.1% operating margin), whereas KOPN carries 50.7/100 (HOLD) at $2.58 (N/M Forward P/E, -30.5% operating margin). Growth vs. Quality Trade-Off: SIF earns the overall head-to-head edge with a stronger Unified Composite Score (51.4/100 HOLD vs. KOPN 50.7/100 HOLD) and 1.94β · 67% Vol risk profile, whereas KOPN leads top-line expansion (+52.1% YoY revenue growth, 17.03x PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: SIF is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 26.6); meanwhile KOPN is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
KOPN leads the Growth & Scale pillar: SIF posts +18.3% YoY revenue growth and N/A YoY earnings growth on $99M TTM revenue (16.6% gross margin, 5.1% operating margin), compared with KOPN at +52.1% YoY revenue growth and +0.0% YoY earnings growth on $200M TTM revenue (28.8% gross margin, -30.5% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), SIF cumulative revenue shifted -27.3% while KOPN shifted +100.0%. In operating R&D and SG&A reinvestment, SIF deploys 11.5% of Rev ($11M) (0 90-day corporate R&D disclosures) versus 59.3% of Rev ($119M) (0 disclosures) for KOPN.
SIF screens cheaper on headline valuation multiples. SIF trades at 11.2x Forward P/E, 23.4x Trailing P/E, 1.64x PEG, and 1.0x EV/Revenue (3.0% FCF margin), whereas KOPN trades at N/M Forward P/E, N/M Trailing P/E, 17.03x PEG, and 2.1x EV/Revenue (-34.4% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against SIF (10.1% ROE) versus KOPN (1.1% ROE) capital efficiency.
In options market volatility and institutional positioning, SIF carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.94β · 67% Vol realized risk). By comparison, KOPN carries 93.3% implied volatility (14th %ile, Compressed (<25th %ile)), a 0.45x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (4.57β · 123% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Launch Custom Ticker Comparison →
KOPN vs SIF · Reverse Pair
SIF vs CVU
· Sector Peer
SIF vs DCO
· Sector Peer
SIF vs IA
· Sector Peer
KOPN vs HIMX
· Sector Peer
INTC vs AMD
· x86 & Data Center CPU
NVDA vs AMD
· AI Accelerators
TSM vs ASML
· Foundry & Lithography
MSFT vs GOOGL
· Hyperscale Cloud & AI
AAPL vs META
· Consumer Ecosystem
LLY vs NVO
· GLP-1 Biopharma